Nearly 50% of people with multiple sclerosis (MS) report pronounced fatigue, which has a significantly negative effect on their well-being, a new study from Finland has found. In an analysis of data from more than 500 patients from the Finnish MS registry, individuals with self-perceived fatigue were more likely…
Read more
For every 1,000 employees in the U.S., about $580,000 is spent each year in excess healthcare costs and lost work time from five autoimmune diseases alone, including multiple sclerosis (MS), a report from healthcare startup Welltheory shows. This represents about 5% of the typical annual healthcare spending for a…
More Stamina, a gamified mobile app, helped a small group of people with multiple sclerosis (MS) better manage their fatigue by becoming more aware of their energy levels and planning their activities more effectively, according to a study from Finland. “Fatigue is an invisible but life-altering symptom…
Treatment with Tysabri (natalizumab) may help delay disability progression in people with secondary progressive multiple sclerosis (SPMS) over Rebif (interferon beta-1a), an analysis of data from two clinical trials suggests. While the trials initially failed to demonstrate slowing disease progression, a significant benefit was observed when accounting…
Sacral neuromodulation (SNM), in which an implanted device delivers mild electrical pulses to the nerves that control the bladder, led to sustained improvements in urinary function in half of people with multiple sclerosis (MS) who underwent surgery to have the device put into place, according to a review of…
Get regular updates to your inbox.
